NEUE: NeueHealth Inc. Price to Sales

Symbol and logo of brand NeueHealth, Inc. (NEUE)

Management restructuring at NeueHealth, Inc. (NEUE) aimed at stabilizing margins is creating the groundwork for an asset revaluation, and the current price-to-sales ratio on the GURU.Markets terminal confirms this, with the current mark equal to 0.10. Revenues are based on Medicare services, while the implementation of digital platforms connecting physicians with patients increases billing transparency and overall treatment efficiency.

NEUE: NeueHealth, Inc. P/S Multiple 02/21/2024 - 10/18/2025

Metric breakdowns and analytics for NeueHealth, Inc. (NEUE)

- stock value and consensus price forecast:
Stock Price neuehealth.com|NEUE - Analyst Consensus Forecast
- market capitalization information:
Market Value NeueHealth Corp|NEUE - Enterprise Value
- shareholders' equity book value data:
Accounting Value of a Share NeueHealth|NEUE - Book Capitalization|Market-to-Book Ratio neuehealth.com|NEUE - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital NeueHealth, Inc.|NEUE - Long-Term Debt to Equity|Short-Term Debt to Equity neuehealth.com|NEUE - Company Total Debt|Debt to Book Capital NeueHealth Corp|NEUE - Company Long-Term Debts|Company Short-Term Loans and Borrowings NeueHealth|Intermediate Coverage Ratio neuehealth.com
- earnings and valuation multiples information:
NEUE - Net Profit|Company Profit Forecast NeueHealth, Inc.|NEUE - Price to Earnings Ratio|Price to Future Earnings Ratio neuehealth.com|NEUE - PEG Multiple|Enterprise Value to EBITDA Ratio NeueHealth Corp|NEUE - Operating profit before deduction of amortization|Net earnings per share for the last four quarters NeueHealth|NEUE - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months neuehealth.com|NEUE - Earnings growth in current year|Expected net earnings per share growth next year NeueHealth, Inc.
- issuer revenue and sales details:
NEUE - Company Sales|Projected Sales Volume neuehealth.com|NEUE - P/S Multiple|Market Cap to Future Revenue Ratio NeueHealth Corp
Summary company analytics:NeueHealth Inc.
Signature product of neuehealth.com

The scale of NeueHealth, Inc. (NEUE) operations and market expectations are reflected in the fluctuations of the P/S multiple. This ratio compares current market capitalization to annual revenue, determining the value of each dollar of sales. For the investor, this serves as a measure of asset overvaluation, directly dependent on the efficiency of payment management and Medicare Advantage client retention. Long-term consensus is formed through an analysis of the historical extremes of this ratio.

Competing companies

P/S Multiple unitedhealthgroup.com (UNH)|P/S Multiple CI (Cigna)|Aflac Inc. (AFL) - Price to Sales|Humana Health - P/S Multiple|Market Capitalization-to-Revenue Ratio CNC (Centene Health)|MOH: P/S Multiple|Price to Sales maximus.com (MMS)|OSCR (Oscar Health) - P/S Multiple|P/S Multiple Clover Health Investments, Corp.|Price-to-Revenue Ratio Claritev Inc. (CTEV)|Price-to-Revenue Ratio YB (Yuanbao Corp)|Health In Tech - Market Cap to Revenue|Market Cap to Sales Volume EHTH (eHealth Inc.)|GoHealth - P/S Multiple|Market Capitalization-to-Revenue Ratio RELI (Reliance Global Group Inc)|LIFW (LifeWallet) - Market Cap to Revenue|MultiPlan Inc. - Market Capitalization-to-Revenue Ratio